Tag: Viatris
SCOTUS Rejects Sanofi Appeal To Revive EpiPen Suit Against Viatris
The US Supreme Court declined to consider Sanofi SA's antitrust lawsuit against Viatris Inc, alleging that the latter had illegally monopolized the market with...
EpiPen Antitrust Suit Settled For $264M
Viatris, the drugmaker formerly known as Mylan, said on Monday it had agreed to pay $264 million to resolve a class action lawsuit alleging...
Viatris Gets A Win In Long-Running EpiPen Antitrust Suit
According to FiercePharma, Viatris, the drugmaker announced that it's scored a win against serious charges in an antitrust case that's been running for several...
